• Degarelix Acetate: Rapid Androgen Deprivation in Prostate Ca

  2026-06-25

  The reference study presents degarelix acetate as a third-generation GnRH antagonist that achieves swift and sustained testosterone suppression in advanced prostate cancer, avoiding the initial testosterone surge associated with GnRH agonists. These findings highlight a significant step forward in the safety and efficacy of androgen deprivation therapy, with implications for improved patient management and research into endocrine-responsive malignancies.

• Demethyleneberberine in Disease Models: Translational Protoc

  2026-06-25

  Explore Demethyleneberberine (DMB) as a versatile research tool for inflammation, oncology, and neuroprotection. This article delivers protocol-driven guidance and mechanistic insights that go beyond previous reviews, supporting robust assay selection and translational modeling.

• HotStart Universal 2X Green qPCR Master Mix: Mechanistic Rev

  2026-06-24

  HotStart Universal 2X Green qPCR Master Mix utilizes a hot-start Taq polymerase for precise, dye-based real-time PCR gene expression analysis. Incorporation of Green I dye enables robust DNA amplification monitoring, while antibody-mediated polymerase control ensures high specificity. The product supports reproducible quantification and is validated for complex studies such as stemness and metastasis research.

• Repurposing FDA-Approved Drugs to Modulate DNA Repair in CRI

  2026-06-23

  This study systematically screened over 7,000 FDA-approved drugs to identify modulators of DNA double-strand break repair pathways in human iPSCs. The findings reveal new strategies for influencing genome editing outcomes and targeting cancer vulnerabilities through synthetic lethality.

• CBD Modulates Orofacial Inflammatory Pain via Endocannabinoi

  2026-06-23

  This study rigorously investigates how cannabidiol (CBD) alleviates both sensory and emotional aspects of orofacial inflammatory pain in mouse models. Through advanced behavioral and molecular analyses, the research delineates distinct peripheral and central endocannabinoid mechanisms underlying CBD's multidimensional analgesic effects, informing future cannabinoid receptor research and translational pain management.

• Anti-Diabetic Drugs and Fracture Risk: Evidence from Network

  2026-06-22

  A recent systematic review and network meta-analysis synthesized data from 117 randomized controlled trials to clarify how different anti-diabetic drugs affect fracture risk in type 2 diabetes patients. This research provides a comparative framework for understanding safety profiles, highlighting that most agents—including SGLT2 inhibitors such as Ertugliflozin—do not significantly alter fracture risk, while a few agents show either increased or decreased risk.

• QRICH1-Driven ER Stress Amplifies HMGB1 Secretion in HBV Fib

  2026-06-22

  The referenced study demonstrates that QRICH1, a key effector of endoplasmic reticulum (ER) stress, enhances hepatitis B virus (HBV)-induced HMGB1 translocation and secretion in hepatocytes, thereby accelerating hepatic fibrosis. These findings clarify the molecular link between ER stress and fibrogenesis, offering mechanistic insight for future interventions in chronic liver disease.

• EZ Cap™ EGFP mRNA (5-moUTP): Redefining Reporter Assay Preci

  2026-06-21

  Explore how EZ Cap EGFP mRNA 5-moUTP sets a new standard for precision in enhanced green fluorescent protein mRNA assays. Gain deep insights into its molecular engineering and practical impact on translational efficiency, immune evasion, and assay reproducibility.

• AP-2α Suppresses MGMT to Reverse Temozolomide Resistance in

  2026-06-20

  The referenced study establishes AP-2α as a critical regulator of MGMT expression, reducing temozolomide (TMZ) resistance in recurrent glioblastoma by promoting DNA damage. These findings provide a mechanistic basis for targeting the AP-2α/MGMT axis to enhance chemotherapeutic sensitivity in difficult-to-treat GBM.

• Sodium Dicloxacillin Monohydrate: Precision Tools for MSSA R

  2026-06-19

  Sodium dicloxacillin monohydrate delivers reproducible, tunable inhibition of MSSA and Gram-positive bacteria, making it an essential asset for translational infection modeling. This article demystifies protocol optimization, spectrophotometric quantification, and troubleshooting, empowering researchers to fully leverage APExBIO’s rigorously validated product.

• Repurposing Safe Drugs to Modulate DNA Repair in CRISPR Edit

  2026-06-19

  This study systematically screens FDA-approved drugs to modulate DNA double-strand break repair outcomes in human iPSCs, offering new strategies for enhancing precise genome editing and synthetic lethality. The findings establish a robust platform for rational drug selection in disease modeling and gene therapy.

• FH1 Small Molecule: Transforming iPS Cell Differentiation to

  2026-06-18

  FH1 small molecule from APExBIO enables robust, reproducible maturation of iPS-derived hepatocyte-like cells, doubling albumin secretion and enhancing key liver functions. This article details workflow optimizations, advanced applications, and troubleshooting strategies to maximize cultured hepatocyte function enhancement in next-generation research.

• Gemcitabine HCl: Innovations in Preclinical Modeling and Ass

  2026-06-18

  Explore how Gemcitabine HCl advances pancreatic cancer research through precise DNA replication inhibition and practical assay optimization. This article delivers unique insights on integrating multianimal MRI protocols and product-specific handling for robust preclinical workflows.

• Palmitic acid (Hexadecanoic Acid): Technical Use and Protoco

  2026-06-17

  Palmitic acid (SKU N2456) addresses the need for a high-purity, well-characterized saturated long-chain fatty acid in metabolic disorder research, lipid metabolism studies, and investigations of protein palmitoylation. It is not suitable for protocols requiring aqueous solubility or long-term solution storage; precise reconstitution and immediate use are essential for reproducible results.

• Anagliptin (SK-0403): Advanced DPP-4 and Vascular Research W

  2026-06-17

  Anagliptin (SK-0403) empowers researchers to dissect both metabolic and vascular mechanisms, bridging diabetes and cardiovascular endpoints with unrivaled selectivity. This guide delivers actionable protocols, troubleshooting strategies, and translational insights from the latest mechanistic research.

8192 records 13/547 page Previous Next First page 上5页 1112131415 下5页 Last page